The induced pluripotent stem cells production market is projected to grow from USD 1.7 billion in 2025 to USD 4.4 billion by 2035, at a CAGR of 10.0%. Manual iPSC production process will dominate with a 77.6% market share, while cell culture will lead the workflow outlook segment with a 37.3% share.